Clinical Trials on Esophageal Cancer in France

Total 5410 results

Johnson & Johnson Pharmaceutical Research & Development...
Eisai Inc.

Completed

Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

Gastroesophageal Reflux

United States, Belgium, Israel, Poland, Australia, Netherlands, South Africa, Hungary, Bulgaria, Denmark
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Phathom Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Heartburn | Non-Erosive Gastro-Esophageal Reflux Disease

United States
Hospices Civils de Lyon

Recruiting

Assessment of the Quality and Sexual Health Needs of Patients With Advanced-stage Cancer (INTIMI-K)

Advanced Cancer | Sexual Satisfaction

France
Centre Francois Baclesse

Terminated

Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care

Cancer | Palliative Care | Home

France
Institut de cancérologie Strasbourg Europe
Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Recruiting

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer (TNBC-RT2023)

Triple-negative Breast Cancer

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Liquid Biopsies for the Personalized Management of Patients With Hereditary Diffuse Gastric Cancer (LISA-HDGC)

Hereditary Diffuse Gastric Cancer

France
Centre Hospitalier Universitaire de Besancon
National Cancer Institute, France

Completed

Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab (NK-EGFR01)

Gastrointestinal Metastatic Cancer

France
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Centre Francois Baclesse
Roche Pharma AG

Completed

Optimize the Requirements and Preparations in Outpatient Chemotherapy

Cancer | IV Anticancer Therapy

France
GERCOR - Multidisciplinary Oncology Cooperative...
Merrimack Pharmaceuticals

Completed

A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer (DOUBLIRI)

Unresectable Advanced Cancer

France
Assistance Publique Hopitaux De Marseille

Unknown

Assessments and Recommendations for the Implementation of Advance Directives in Oncology (DA)

Patient Having a Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Withdrawn

A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers (TAM-RT)

Anaplastic Thyroid Cancers

France
Centre Antoine Lacassagne
Institut National de la Santé Et de la Recherche Médicale, France

Completed

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib (SUNITRES)

Metastatic Kidney Cancers

France
University Hospital, Montpellier
CBS; MICALIS

Recruiting

Synthetic Metabolic and Genetic Networks for Medical Diagnosics (SynBioDiag)

Cancer | Prostate

France
University Hospital, Clermont-Ferrand

Unknown

Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes (OVOMIV)

Cancer | Fertility

France
UNICANCER
Servier

Recruiting

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer (LOGICAN)

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Esophagus Adenocarcinoma

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer (MONAMI)

MSI | dMMR Colorectal Cancer

France
University Hospital, Montpellier
Centre Hospitalier Universitaire de Nīmes; Institut du Cancer de Montpellier; Oncopole Toulouse

Completed

Intrathecal Analgesia Effects on Cancer Patients Discomfort Symptoms (IT-ESAS)

Refractory Cancer Pain | Intrathecal Analgesia

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer

Gynaecologic or Digestive Pelvic Cancer

France
Centre Hospitalier de Valence

Completed

Antalgic Effects of Well-being Treatments in Cancer Care (Well Being)

Cancer | Cancer Pain

France
Assistance Publique - Hôpitaux de Paris
Eurofins Biomnis

Not yet recruiting

Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects (ASRHACOLS)

Colon Cancer

France
University Hospital, Brest

Recruiting

Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) (PEMBROMIC)

Lung Cancer Stage III | Lung Cancer Stage IV

France
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
Assistance Publique Hopitaux De Marseille

Unknown

Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study. (LIDOSP)

Cancer | Pain With Neuropathic Component

France
Centre Hospitalier le Mans

Recruiting

Development of a Personalised Therapeutic Approach for Cancer Patients With Resting Hypermetabolism (METABO-1)

Cancer

France
Centre Leon Berard

Recruiting

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM) (GOTIM)

GastroEsophageal Cancer

France
CHU de Reims

Completed

The Use of Cannabidiol in Cancer Patients (CANPADIOL)

Cancer

France
National Cancer Institute (NCI)

Suspended

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Esophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditions

United States
Gustave Roussy, Cancer Campus, Grand Paris
AstraZeneca

Recruiting

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva) (POP-DURVA)

Early Small (cT1N0) Triple Negative Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan (SIRINOX)

Digestive Cancer

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Evaluation of the Improvement of Autonomic Nervous System by a Physical Rehabilitation Program Adapted to Adulthood After Chemotherapy or Radiotherapy in Childhood (SALTO_GyV)

Cancer | Sequels | Complications

France
Centre Hospitalier de Bligny
Cureety; Exystat; Pharmaspecific; ProPens

Recruiting

A Study of Telemonitoring in Cancer Patients (MINERVA)

Cancer

France
Institut de Cancérologie de Lorraine

Completed

Unusual Toxicity Induced by Radiotherapy (CRYOTOX)

Cancer

France
Institut Curie

Terminated

FSH-R : Diagnostic Application for Localized Tumors in Cancerology (FRACTal)

Cancer

France
University Hospital, Caen

Unknown

Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events (19-916)

Cancer

France
Institut Bergonié
Institut du Cancer de Montpellier - Val d'Aurelle; UNICANCER

Active, not recruiting

Survival Endpoints for Treatment Evaluation in Subjects Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

Cancer

France
Centre Leon Berard

Completed

Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 (ABORL)

Head and Neck Cancer | Metastatic Cancer | Advanced Cancer

France
Institut Curie

Recruiting

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 (ALCINA4)

Cancer

France
University Hospital, Caen

Recruiting

Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR) (AVATAR)

Cancer

France
Institut Bergonié
National Cancer Institute, France; Institut du Cancer de Montpellier - Val... and other collaborators

Active, not recruiting

Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) (DATECAN-1)

Cancer

France
University Hospital, Clermont-Ferrand

Completed

Evaluation of Patients' Satisfaction With the Dispensation of Their Oral Anticancer Treatment in Community Pharmacy (ORCA)

Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of Clinical and Biological Database (BCBInstitut)

Sarcoma | Breast Cancer | Gynecologic Cancer | Digestive Cancer

France
AstraZeneca

Completed

Impact of GERD on Daily Life (NIS) (Alegria)

GERD

Belgium
Institut Bergonié
National Cancer Institute, France

Completed

Validation of a Screening Tool in Geriatric Oncology (ONCODAGE)

Lymphoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

France
Assistance Publique Hopitaux De Marseille

Unknown

Initiation of Adapted Physical Activity for Patients With Advanced Pediatric Malignancies

Pediatric Cancer

France
BeiGene

Completed

AdvanTIG-203: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Korea, Republic of, Spain, China, Thailand, Taiwan, France
Institut Curie

Recruiting

DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI)

Cancer Patients With Cancer Pain

France
Centre Leon Berard
Novartis

Completed

Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type (TRAHD)

Colorectal Cancer | Metastatic Cancer | Advanced Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
HalioDx; Methodology and quality of life unit in oncology, University hospital...

Unknown

Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment

Colorectal Cancer | Stage III Colon Cancer

France

3

Subscribe